-+ 0.00%
-+ 0.00%
-+ 0.00%

SHARES OF CORCEPT THERAPEUTICS FALL 34.5% PREMARKET AFTER US FDA DECLINES TO APPROVE CO'S DRUG FOR RARE HORMONAL DISORDER

Reuters·12/31/2025 13:23:54

Please log in to view news